Compare RDIB & SENS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RDIB | SENS |
|---|---|---|
| Founded | 1937 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Movies/Entertainment | Industrial Machinery/Components |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 256.7M | 308.5M |
| IPO Year | N/A | 2014 |
| Metric | RDIB | SENS |
|---|---|---|
| Price | $11.09 | $5.60 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $22.70 |
| AVG Volume (30 Days) | 6.8K | ★ 482.8K |
| Earning Date | 01-01-0001 | 05-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $16,389,000.00 |
| Revenue This Year | N/A | $70.20 |
| Revenue Next Year | $13.42 | $59.10 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 19.85 |
| 52 Week Low | $6.70 | $0.41 |
| 52 Week High | $17.40 | $8.75 |
| Indicator | RDIB | SENS |
|---|---|---|
| Relative Strength Index (RSI) | 36.40 | 28.26 |
| Support Level | $8.95 | $5.46 |
| Resistance Level | $12.51 | $8.55 |
| Average True Range (ATR) | 0.55 | 0.49 |
| MACD | -0.27 | -0.26 |
| Stochastic Oscillator | 3.18 | 7.85 |
Reading International Inc is a diversified company, engaged in the development, ownership, and operation of multiplex cinemas and retail and commercial real estate in the United States, Australia, and New Zealand. It operates through two segments: the Cinema segment includes Reading Cinemas, Angelika Film Center, Consolidated Theatres, and City Cinemas; the Real Estate segment includes real estate development and the rental or licensing of retail, commercial and live theater assets.
Senseonics Holdings Inc is a medical technology company. It is focused on the design, development, and commercialization of glucose monitoring system, which helps people to manage their diabetes community with differentiated, long-term implantable glucose management technology. Its products and services include a Continuous glucose monitoring system, Sensor, Smart transmitter, and Mobile app. The firm has a Glucose monitoring product segment. The majority of the revenue is generated outside of the United States.